Recombinant Human Activin RIIA/ACVR2A-Protein, Active
Beta LifeScience
SKU/CAT #: BLK-00442P-100UG

Human Activin RIIA on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Human Activin RIIA/ACVR2A-Protein, Active
Beta LifeScience
SKU/CAT #: BLK-00442P-100UG
Collections: High-quality recombinant proteins, Other recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Human Activin RIIA/ACVR2A-Protein is expressed from HEK293 with His tag at the C-Terminus.It contains Ala20-Pro135. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | P27037 |
Target Symbol | Activin RIIA/ACVR2A |
Species | Human |
Expression System | HEK293 |
Tag | C-His |
Expression Range | Ala20-Pro135 |
Mol. Weight | The protein has a predicted MW of 14.50 kDa. Due to glycosylation, the protein migrates to 30-42 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Activity | Immobilized Human Activin A, No Tag at 5ug/ml (100ul/well) on the plate. Dose response curve for Human Activin RIIA, His Tag with the EC50 of 0.23ug/ml determined by ELISA. Contact us for detailed testing images. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | Activin A receptor type 2A (ACVR2A) is a membrane receptor in the transforming growth factor- beta (TGF-β signaling pathway, which is involved in the regulation of cell proliferation, migration, and apoptosis. Loss of ACVR2A has an important role in cancer progression and distant metastasis and may serve as a prognostic marker in patients with colon cancer. |